Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
NOVABAY PHARMACEUTICALS, Inc. Add to My Watchlist (AMEX: NBY) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     NOVABAY 2.24 -0.01 (-0.44%) 15,550
5980 Horton Street
Suite 550
Emeryville, CA 94608 US
(510) 899-8800
(510) 225-0371 fax
www.novacal.com
CEO Dr. Ramin (Ron) Najafi, Ph.D.
Auditor Davidson & Company LLP
Exchange Traded AM
ISIN Number US66987P1021
CIK Number 1389545
NAICS Code 325412
Business Summary
A mid-stage biopharmaceutical company, which is focused on developing product candidates for the treatment or prevention of a range of infections in hospital and non-hospital environments.
Number of Employees 31
Share Fundamentals
Market Cap 52.09M
Shares Outstanding 23.25M
Float 17.84M
Short Interest 5.40K
Financial Strength
Revenue (TTM) $10,388,000
Earnings (TTM) -$2,254,000
Quick Ratio 2.3:1
Current Ratio 2.5:1
Total Debt/Equity 0.06:1
Profitability
Gross Margin N/A
EBITDA Margin -18.7%
Profit Margin -21.7%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs